ML-SI1
Based on 7 publication(s) in Google Scholar
ML-SI1, a racemic mixture of diastereomers, is a TRPML inhibitor with an IC50 value of 15 μM for TRPML1.
For research use only. We do not sell to patients.
- Purity: 99.80%
- Formula: C23H26Cl2N2O3
- Molecular Weight:449.37
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) ML-SI1
More- Burns Trauma. 2025 Feb 17:13:tkaf007. [Abstract]
- Acta Pharmacol Sin. 2024 May;45(5):900-913. [Abstract]
- Ecotoxicol Environ Saf. 2024 Oct 1:284:116890. [Abstract]
- Ecotoxicol Environ Saf. 2023 Jun 1:257:114942. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2023 Jan;1870(1):119386. [Abstract]
- Mol Biol Cell. 2024 May 1;35(5):ar70. [Abstract]
- bioRxiv. 2026 Jun 18:2026.06.16.731945. [Abstract]
-
WB
-
IF
-
WB
-
Bio/Physico-chemical Assay
-
Cell Imaging/Staining
Biological Activity
IC50: 15 μM (TRPML1)[1]
ML-SI1 is an inseparable racemic mixture of cis-/trans-isomers (55:45) in a short synthetic sequence and its inhibitory activity on hTRPML1 (and a weak effect on TRPML2) after activation with ML-SA1. Fura-2 based single cell calcium imaging experiments confirmed that the synthesized racemic ML-SI1 (10 μM) has an inhibitory effect on hTRPML1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Solid
-
Molecular Weight 449.37
-
Formula C23H26Cl2N2O3
-
Color Off-white to yellow
-
SMILES
O=C(N1C2=CC=C(C=C2C(C1C)CCN3CCOCC3)OC)C4=C(Cl)C(Cl)=CC=C4.[Mixture of diastereomers]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (7)
-
Journal Impact Factor
-
Most Recent
-
Burns Trauma
Flufenamic acid inhibits pyroptosis in ischemic flaps via the AMPK-TRPML1-Calcineurin signaling pathway. [Abstract]2025 Feb 17:13:tkaf007. PMID: 40655077
ML-SI1 purchased from MedChemExpress. Usage Cited in: Burns Trauma. 2025 Feb 17:13:tkaf007. [Abstract]
ML-SI1 (1 mg/kg; i.p.; 30 min) countered FFA's effects on TFE3 nuclear levels and activation of the signaling pathway in C57BL/6J mice.
-
Acta Pharmacol Sin
Corynoxine promotes TFEB/TFE3-mediated autophagy and alleviates Aβ pathology in Alzheimer's disease models. [Abstract]2024 May;45(5):900-913. PMID: 38225393
ML-SI1 purchased from MedChemExpress. Usage Cited in: Acta Pharmacol Sin. 2024 May;45(5):900-913. [Abstract]
ML-SI1 (10 μM; 24 h) blocked Cory-induced TFEB/TFE3 nuclear translocation in N2a cells.
ML-SI1 purchased from MedChemExpress. Usage Cited in: Acta Pharmacol Sin. 2024 May;45(5):900-913. [Abstract]
ML-SI1 (10 μM; 24 h) blocked the increased LC3B-II and the decreased SQSTM1 in N2a cells.
ML-SI1 purchased from MedChemExpress. Usage Cited in: Acta Pharmacol Sin. 2024 May;45(5):900-913. [Abstract]
ML-SI1 blocked the transient and significant increase in Ca2+ concentration in N2a cells induced by cory in Ca2+-free buffer.
-
Ecotoxicol Environ Saf
Lysosomal iron accumulation and subsequent lysosomes-mitochondria iron transmission mediate PFOS-induced hepatocyte ferroptosis. [Abstract]2024 Oct 1:284:116890. PMID: 39146593
ML-SI1 purchased from MedChemExpress. Usage Cited in: Ecotoxicol Environ Saf. 2024 Oct 1:284:116890. [Abstract]
ML-SI1 (10 μM; 1 h) further heightened lysosomal iron levels in PFOS-exposed L-O2 cells.
-
Ecotoxicol Environ Saf
Blunting ROS/TRPML1 pathway protects AFB1-induced porcine intestinal epithelial cells apoptosis by restoring impaired autophagic flux. [Abstract]2023 Jun 1:257:114942. PMID: 37086622
ML-SI1 purchased from MedChemExpress. Usage Cited in: Ecotoxicol Environ Saf. 2023 Jun 1:257:114942. [Abstract]
ML-SI1 (1.25 μM; 24 h) significantly reduces the AFB1-induced number of autophagosomes in IPEC-J2 cells.
ML-SI1 purchased from MedChemExpress. Usage Cited in: Ecotoxicol Environ Saf. 2023 Jun 1:257:114942. [Abstract]
ML-SI1 (1.25 μM; 24 h) significantly reduces the AFB1-induced expression of LC3, SQSTM1, Cleaved-Caspase3 and TRPML1 in IPEC-J2 cells.
-
Biochim Biophys Acta Mol Cell Res
Impaired autophagic flux and dedifferentiation in podocytes lacking Asah1 gene: Role of lysosomal TRPML1 channel. [Abstract]2023 Jan;1870(1):119386. PMID: 36302466 -
Mol Biol Cell
Stress-induced microautophagy is coordinated with lysosome biogenesis and regulated by PIKfyve. [Abstract]2024 May 1;35(5):ar70. PMID: 38536415 -
bioRxiv
2026 Jun 18:2026.06.16.731945. PMID: 42367851
Solvent & Solubility
DMSO : 100 mg/mL (222.53 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (5.56 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (5.56 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.2253 mL | 11.1267 mL | 22.2534 mL | 55.6334 mL |
| 5 mM | 0.4451 mL | 2.2253 mL | 4.4507 mL | 11.1267 mL | |
| 10 mM | 0.2225 mL | 1.1127 mL | 2.2253 mL | 5.5633 mL | |
| 15 mM | 0.1484 mL | 0.7418 mL | 1.4836 mL | 3.7089 mL | |
| 20 mM | 0.1113 mL | 0.5563 mL | 1.1127 mL | 2.7817 mL | |
| 25 mM | 0.0890 mL | 0.4451 mL | 0.8901 mL | 2.2253 mL | |
| 30 mM | 0.0742 mL | 0.3709 mL | 0.7418 mL | 1.8544 mL | |
| 40 mM | 0.0556 mL | 0.2782 mL | 0.5563 mL | 1.3908 mL | |
| 50 mM | 0.0445 mL | 0.2225 mL | 0.4451 mL | 1.1127 mL | |
| 60 mM | 0.0371 mL | 0.1854 mL | 0.3709 mL | 0.9272 mL | |
| 80 mM | 0.0278 mL | 0.1391 mL | 0.2782 mL | 0.6954 mL | |
| 100 mM | 0.0223 mL | 0.1113 mL | 0.2225 mL | 0.5563 mL |